You won’t be able to ignore a government shutdown. From delayed business loans to slower mortgage applications and postponed food inspections, the effects...
Avalyn Pharma announced Wednesday that it closed a $175 million Series C round, which it plans to put toward two Phase II studies of inhaled versions...
Vaccination Offers 'No Meaningful Protection' Against Long COVID: Study Authored by Marina Zhang via The Epoch Times (emphasis ours), Findings...
New York and Cambridge, UK — Recent research demonstrates that protein phase separation (PPS) is widely present in cells and drives a variety of important...
A clinical trial has launched to test whether early intensive immune modulation for hospitalized COVID-19 patients with relatively mild illness is beneficial....
Dana-Farber Cancer Institute announced on Sept. 14 that it is securing a new joint venture with Beth Israel Deaconess Medical Center, marking a breakup...
The Novo Nordisk Foundation revealed Thursday it has committed €127 million ($135.4 million) to build a new cell therapy facility in Denmark, which is...
September 21, 2023, NEW YORK – A Ludwig Cancer Research study has shown that combining adoptive T cell therapy (ACT) with an innovative, personalized...
WINSTON-SALEM, N.C. – Sept. 21, 2023 – Being diagnosed with a serious illness such as cancer brings many physical, emotional and financial burdens,...
The No. 1 cause of death in children is trauma. There are an estimated 2,000 pediatric deaths from traumatic bleeding in the U.S. each year that...
Every year, without fail, the Endpoints 11 proves to be the most challenging project I face — and definitely remains the most fun. In an industry...
Leesburg, VA, September 20, 2023—According to an accepted manuscript published in the American Journal of Roentgenology (AJR), upgrade and downgrade...
SAN ANTONIO (Sept. 20, 2023) – Capitalizing on the power of its longstanding international partnership portfolio, Texas Biomedical Research Institute...
A team from the University of Massachusetts Amherst and The University of Texas at Austin is among 13 institutional partners chosen by the CDC’s Center...
SEPTEMBER 20, 2023, NEW YORK – In exploring an aspect of how killer T cells generate the raw materials required for their proliferation, a Ludwig Cancer...
These blood tests results need care when interpreting, and they can not they predict how the disease will affect each person.
Deep brain stimulation can help some people with treatment-resistant depression feel better, but it can be unclear whether a bout of low mood is a relapse...
The Centre for Ion Beam Applications (CIBA), a multidisciplinary research centre at the National University of Singapore (NUS), has recently been designated...
In this live-streamed episode of Trade To Black, we have a captivating interview with Doug Drysdale, the CEO of Cybin. It’s been a big week for...
Liver cancer is one of the most prevalent and deadly types of cancer worldwide. Most patients are diagnosed at an advanced stage, which leaves them with...
Recent evidence strongly implicates infection by the Epstein-Barr virus (EBV) as the trigger for development of multiple sclerosis (MS). An international...
Seattle biotech company Deverra Therapeutics is raising cash for its cellular immunotherapies platform that helps doctors treat patients with cancer and...
FDA Has 'Gone Rogue' In Its Approval Of New COVID-19 Boosters: Dr. Robert Malone Authored byh Tom Ozimek and Joshua Philipp via The Epoch...
DALLAS (SMU) – SMU chemistry professor John Buynak and his team have received a $3.5 million, 5-year grant from the National Institutes of Health to...
Arialys is developing an antibody therapeutic, ART5803, to treat anti-NMDA receptor encephalitis (ANRE), one of the most common forms of autoimmune encephalitis....
CAMBRIDGE, MA — One promising approach to treating Type 1 diabetes is implanting pancreatic islet cells that can produce insulin when needed, which can...
PHILADELPHIA—(Sep. 18, 2023)—Zachary Schug, Ph.D., assistant professor in the Molecular and Cellular Oncogenesis Program of the Ellen and Ronald Caplan...
Building on its infectious disease work in Covid-19, malaria and tuberculosis, BioNTech is now rolling out a Phase I/II test of a jab to protect against...
When Molly Gibson, PhD, joined Flagship Pioneering in 2017, she had been mulling over the question of what the main drivers of biology were for rethinking...
The FDA approved a new JAK inhibitor, momelotinib, from GSK for adults with the rare bone marrow cancer myelofibrosis who also have anemia. The approval...